FINNENCE ▪ THE WIRE FILE
THE WIRE · № 84040
News▼ Bearish
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A private placement plus warrant inducement dilutes holders and signals funding pressure.
Small biotech financing is dilutive to existing holders
CATALYST TO WATCH
CDMO and therapeutic program updates
MAIN RISK
Warrant overhang and further dilution
FULL DISPATCH
JERUSALEM, Oct. 16, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company operating a growing contract development and manufacturing organization ("CDMO") alongside an immunology-focused therapeutic development...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Withings BodyScan 2 Named One of TIME's Best Inventions of 20262026-10-16 12:00 UTC
Withings BodyScan 2 Named One of TIME's Best Inventions of 20262026-10-16 12:00 UTC
→CORRELATIONshares Healthcare
Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors2026-10-16 12:00 UTC
Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors2026-10-16 12:00 UTC
→CORRELATIONshares Healthcare
Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma2026-10-16 12:00 UTC
Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma2026-10-16 12:00 UTC
→CORRELATIONshares Healthcare
Nabsys Launches RepX™ for Repeat Expansion Analysis Ahead of ASHG 20262026-10-16 12:00 UTC
Nabsys Launches RepX™ for Repeat Expansion Analysis Ahead of ASHG 20262026-10-16 12:00 UTC
→CORRELATIONshares Healthcare
Antihypertensive Drugs Market to Reach USD 30.92 Billion by 20352026-10-16 12:24 UTC
Antihypertensive Drugs Market to Reach USD 30.92 Billion by 20352026-10-16 12:24 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.